Summary:
Nelotanserin for Potential Treatment of REM Sleep Behavior Disorder in DLB and PDD
An estimated 80% of people with dementia with Lewy bodies (DLB) and 60% of people with Parkinson’s disease experience REM sleep behavior disorder (RBD), a serious condition where a person physically and/or vocally acts out their dreams. A clinical study is now evaluating nelotanserin, an investigational medication, as a treatment for RBD in people with DLB or Parkinson’s disease dementia (PDD). Learn more about local participation here. http://studies.clin-edge.com/rbd-npd/